lifonebart   Click here for help

GtoPdb Ligand ID: 14696

Synonyms: VHB-937 | VHB937
Compound class: Antibody
Comment: Lifonebart (VHB937) is a fully human anti-TREM2 monoclonal antibody, with agonist activity at TREM2 on microglia [2]. It was designed for potential to treat inflammation-associated neurodegenerative conditions.
Peptide sequences for the heavy and light chains of lifonebart match sequences that are claimed in patent US11492402B2, specifically for antibody clones with the code name MOR044698 [1].
Click here for help
References
1. Brand V, Feuerbach D, Gasparini F, George N, Schaadt E, Shimshek D, Srinivas H, Waldhuber M, Wilken R. (2022)
TREM2 stabilizing antibodies.
Patent number: US11492402B2. Assignee: Novartis AG. Priority date: 14/10/2019. Publication date: 08/11/2022.
2. Stangel M, Feuerbach D, Shimshek D, Gasparini F, Galimberti I, George Nm Peraus G, Sovago J. (2024)
VHB937, a TREM2 Stabilizing and Activating Antibody Strongly Reduces Pathology After Peripheral Administration in a Broad Range of Animal Models for Neuroinflammation and Neurodegeneration (P4-4.004).
Neurology, 102 (7_supplement_1): 5160. DOI: 10.1212/WNL.0000000000205610